Skip to main content
NEXTURNBIOSCIENCE Co., LTD logo

NEXTURNBIOSCIENCE Co., LTD — Investor Relations & Filings

Ticker · 089140 ISIN · KR7089140008 KO Professional, scientific and technical activities
Open in API
Filings indexed 486 across all filing types
Latest filing 2025-05-15 AGM Information
Country KR South Korea
Listing KO 089140

About NEXTURNBIOSCIENCE Co., LTD

http://www.nexturn.co.kr

NEXTURNBIOSCIENCE Co., LTD. is a specialized manufacturer of Computer Numerical Control (CNC) automatic lathes, with a focus on Swiss-type models. The company develops and produces a range of machines, including both guide bush and non-guide bush types, utilizing proprietary technology. In addition to its core machinery business, NEXTURNBIOSCIENCE leverages its expertise in ultra-precision manufacturing to produce essential functional components. These high-quality parts serve critical applications across diverse sectors, including information technology (IT), construction equipment, and the medical industry, reflecting the company's expanding business scope.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집결의 (임시주주총회)
AGM Information Classification · 1% confidence The document is a formal regulatory filing from a Korean company (Nexturn Bio) regarding the 'Resolution to Convene a General Meeting of Shareholders' (specifically an Extraordinary General Meeting). It details the date, location, and agenda items (such as changes to the Articles of Incorporation and business purposes). This type of document is a standard regulatory disclosure for shareholder meetings, which falls under the 'Proxy Solicitation & Information Statement' category as it provides the necessary information for shareholders to understand the meeting agenda.
2025-05-15 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of Extraordinary General Meeting' (주주총회소집공고) for Nexturn Bioscience. It outlines the meeting agenda, including a proposal for the amendment of the Articles of Incorporation, and provides information for shareholders regarding voting procedures and proxy solicitation. This document is a standard proxy statement/information statement sent to shareholders to request their participation and votes for an upcoming meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-05-15 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy/Proxy Statement) for Nexturn Bioscience. It contains detailed information regarding the solicitation of proxies for an upcoming shareholder meeting, including the purpose of the meeting, the agenda (specifically amendments to the Articles of Incorporation), and instructions for shareholders to exercise their voting rights. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI).
2025-05-15 Korean
전환가액의조정
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from a Korean company (Nexturn Bio) regarding the adjustment of the conversion price of convertible bonds (CB). This type of disclosure, which details changes to capital structure instruments like convertible bonds, falls under the category of capital and financing updates.
2025-05-13 Korean
전환가액의조정
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing from a Korean company (Nexturn Bio) regarding the adjustment of the conversion price of convertible bonds (CB). This type of disclosure is a standard corporate action related to capital structure and financing instruments. Since it specifically details the adjustment of conversion prices for existing debt instruments, it falls under the 'Capital/Financing Update' category.
2025-05-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically regarding collateral loan extensions for (주)넥스턴바이오사이언스 by (주)스튜디오 산타클로스 엔터테인먼트. This falls under the category of Major Shareholding Notification.
2025-05-07 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.